Who owns UNICYCIVE THERAPEUTICS INC?
- Ticker: UNCY
- CUSIP Number: 90466y202
Tip: Access positions for across all investors
Analyze quarterly positions in Unicycive Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Unicycive Therapeutics stock
Who bought or sold UNICYCIVE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 1.8M | $7.8M | 57% | Sep 2025 |
|
| Octagon Capital Advisors | 1.0M | $4.4M | 0% | Sep 2025 |
|
| Nantahala Capital Management | 939k | $4.1M | 0% | Sep 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 797k | $3.5M | 0% | Sep 2025 |
|
| Vanguard Group | 659k | $2.9M | 9% | Sep 2025 |
|
| Logos Global Management | 474k | $2.1M | 0% | Sep 2025 |
|
| Geode Capital Management | 126k | $548k | 114% | Sep 2025 |
|
| Squarepoint Ops | 117k | $512k | 100% | Sep 2025 |
|
| Longwood Capital Partners | 60k | $262k | -5% | Sep 2025 |
|
| State Street Corporation | 55k | $239k | 338% | Sep 2025 |
|
| Goldman Sachs Group | 45k | $197k | 100% | Sep 2025 |
|
| Citadel Advisors | 42k | $182k | 100% | Sep 2025 |
|
| XTX Topco | 38k | $165k | 100% | Sep 2025 |
|
| BlackRock | 36k | $159k | 100% | Sep 2025 |
|
| Northern Trust | 33k | $143k | 203% | Sep 2025 |
|
| Chicago Partners Investment | 27k | $127k | 100% | Sep 2025 |
|
| Cubist Systematic Strategies | 24k | $104k | 100% | Sep 2025 |
|
| UBS Group | 5.4k | $24k | 100% | Sep 2025 |
|
| Morgan Stanley | 1.0k | $4.8k | 100% | Jun 2025 |
|
| SBI Securities | 560.00 | $2.4k | 1% | Sep 2025 |
|
| Rockefeller Capital Management | 500.00 | $2.2k | 100% | Sep 2025 |
|
| TFC Financial Management | 300.00 | $1.3k | 100% | Sep 2025 |
|
| Fortitude Family Office | 107.00 | $467.001500 | 100% | Sep 2025 |
|
| Harbour Investments | 100.00 | $436.000000 | 0% | Sep 2025 |
|
| Barclays | 80.00 | $349.000000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 55.00 | $239.998000 | 100% | Sep 2025 |
|
| Bogart Wealth | 6.00 | $25.999800 | 0% | Sep 2025 |
|
| Danske Bank A/s | 1.00 | $4.000000 | 100% | Sep 2025 |
|
Who sold out of Unicycive Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Jun 2025 | 12k | $56k |
| Lazard Asset Management | Jun 2025 | 12k | $55k |